Products

MAGENTIQ-COLO (ME-APDS)
Magentiq Eye Ltd.
Gastroenterology AI
MAGENTIQ-COLO (ME-APDS) is an FDA-cleared AI-powered software that assists gastroenterologists in real-time during colonoscopy procedures to detect polyps, aiming to improve adenoma detection rates and reduce the incidence of colorectal cancer.
MAGENTIQ-COLO™
Magentiq Eye
Gastroenterology AI
MAGENTIQ-COLO™ is an AI-powered computer-aided detection and diagnosis system for colonoscopy, assisting gastroenterologists in real-time polyp detection, characterization, and quality assessment to improve diagnostic accuracy and reduce missed lesions.
ME-APDS™
Magentiq Eye
Gastroenterology AI
Magentiq Eye's ME-APDS™ (MAGENTIQ-COLO™) is an FDA-cleared AI-aided colonoscopy system that provides real-time polyp detection to enhance diagnostic accuracy and improve patient outcomes in gastroenterology.

See all 3 products →

About Magentiq Eye

Magentiq Eye is a healthcare AI company specializing in advanced decision-support software for gastrointestinal endoscopy. Their flagship product, MAGENTIQ-COLO™, is an FDA-cleared and CE-marked AI-aided colonoscopy solution designed to assist physicians in real-time polyp detection during endoscopic procedures. The system leverages deep learning, computer vision, and video analysis technologies to identify suspicious lesions, such as polyps, by highlighting them with bounding boxes on the display monitor. This technology significantly enhances adenoma detection rates (ADR) and reduces adenoma miss rates (AMR), with clinical studies demonstrating a 26% relative increase in ADR and a 48% relative decrease in AMR, ultimately contributing to a reduction in colorectal cancer incidence and mortality.

MAGENTIQ-COLO™ integrates seamlessly into existing clinical workflows, acting as an ‘additional eye’ for endoscopists without disrupting the procedure. Beyond real-time detection, the system provides valuable insights such as polyp size category and type estimation, and generates comprehensive AI-powered reports. Recent versions have expanded capabilities to include AI-based endoscopic tool detection, procedural quality (CAQ) metrics like automated Boston Bowel Preparation Score (BBPS) assessment, and cecum detection, further supporting high-quality colonoscopy outcomes. Magentiq Eye is also actively developing and clinically trialing AI tools for other gastrointestinal indications, including early dysplasia detection in Barrett’s esophagus, ulcerative colitis, and gastric intestinal metaplasia, aiming to provide a comprehensive ‘AI suit’ for gastroenterology.

Focus Areas

AI-aided colonoscopy gastroenterology diagnostics polyp detection computer vision deep learning medical device software real-time decision support computer-aided detection (CADe) computer-aided diagnosis (CADx)

Business Intelligence

Key InvestorsaMoon Fund, Norgine Ventures BV, Nina Capital, Namarel Ventures SL, Nova Capital, Sake Bosch, Roon Doornink, Neuron.VC, Impact Assets, Becton Dickinson, David E. Weekly, Leonard Speiser
PartnershipsPENTAX Medical (distribution partnership for U.S. market)
TechnologyCloud-native, AI, deep learning, computer vision, video analysis technologies, real-time software, integrates with standard endoscopy towers, CADe (computer-aided detection), CADx (computer-aided diagnosis)
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

Specialization: AI-Aided Colonoscopy
Magentiq Eye's core expertise lies in developing AI-powered solutions for colonoscopy, specifically the MAGENTIQ-COLOu2122 system, to enhance the detection of polyps and improve diagnostic accuracy in gastroenterology.
Gastroenterology Diagnostics
The company focuses on transforming diagnostic capabilities within gastroenterology, offering real-time decision support during endoscopic procedures.
Polyp Detection (CADe)
MAGENTIQ-COLOu2122 is a computer-aided detection (CADe) system that uses AI to analyze colonoscopy video output in real-time, highlighting adenoma lesions to assist physicians in detecting polyps.
Computer Vision & Deep Learning
Their technology is built upon cutting-edge artificial intelligence, deep learning, computer vision, and video analysis to process and interpret video frames from colonoscopes.
Medical Device Software
MAGENTIQ-COLOu2122 is a software-based medical device that has received FDA 510(k) clearance in the US and CE Mark approval in Europe.
Real-time Decision Support
The system provides immediate, real-time feedback to gastroenterologists by displaying bounding boxes around suspicious areas on the video output, acting as an 'additional eye' during the procedure.
Computer-Aided Diagnosis (CADx)
CE-marked versions of MAGENTIQ-COLOu2122 offer advanced CADx capabilities, including real-time polyp size estimation and characterization, with a regulatory roadmap for future US availability.
Automated Quality Metrics
Newer versions include CE-marked features like automated real-time and offline evaluation of bowel cleanliness (BBPS) and AI-based cecum detection for objective documentation of preparation quality and complete examination.
Physician Tip

Magentiq Eye's MAGENTIQ-COLOu2122 system is designed to significantly enhance colonoscopy outcomes by providing real-time, AI-powered polyp detection without altering the existing clinical workflow. Physicians can expect a notable increase in Adenoma Detection Rate (ADR) and a reduction in the Adenoma Miss Rate (AMR), which directly contributes to preventing colorectal cancer. The system's high sensitivity (99.6% polyp-wise sensitivity) and specificity (98%) mean fewer missed polyps and reduced distracting false positives, allowing for more precise and confident decision-making. Furthermore, the system offers additional insights like polyp size and type (in CE-marked versions) and automated reporting, streamlining documentation and improving overall procedure quality. This technology can also help bridge the experience gap among physicians, allowing less experienced endoscopists to achieve higher detection rates.

The MAGENTIQ-COLOu2122 computing device acquires digital video output signals directly from local endoscopy towers. It is compatible with leading endoscopy systems, including Olympus, Fujinon, Pentax, and Sonoscape, ensuring seamless integration into existing clinical setups. The system operates as a 'plug-and-play' solution, maintaining the clinical workflow without requiring changes to the procedure itself. Video output with highlighted polyps can be displayed on the main screen or a separate monitor. Recorded videos and generated reports can be saved and exported for further examination and documentation.

Products by Magentiq Eye

3 products in the directory

MAGENTIQ-COLO (ME-APDS)
Magentiq Eye Ltd.
Gastroenterology AI
MAGENTIQ-COLO (ME-APDS) is an FDA-cleared AI-powered software that assists gastroenterologists in real-time during colonoscopy procedures to detect polyps, aiming to improve adenoma detection rates and reduce the incidence of colorectal cancer.
MAGENTIQ-COLO™
Magentiq Eye
Gastroenterology AI
MAGENTIQ-COLO™ is an AI-powered computer-aided detection and diagnosis system for colonoscopy, assisting gastroenterologists in real-time polyp detection, characterization, and quality assessment to improve diagnostic accuracy and reduce missed lesions.
ME-APDS™
Magentiq Eye
Gastroenterology AI
Magentiq Eye's ME-APDS™ (MAGENTIQ-COLO™) is an FDA-cleared AI-aided colonoscopy system that provides real-time polyp detection to enhance diagnostic accuracy and improve patient outcomes in gastroenterology.

Reviews & Opinions

No web reviews on file yet for Magentiq Eye. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Magentiq Eye.

Loading videos...

Videos load interactively. If none appear, search YouTube for Magentiq Eye →

View all on YouTube

Press & Coverage

PR Newswire
MAGENTIQ EYE Secures Series A Investment Led by aMoon to Drive the Future of AI-Powered Gastroenterology
MAGENTIQ EYE announced the completion of its Series A funding round, led by aMoon, to advance its FDA- and CE-approved MAGENTIQ-COLOu2122 software for AI-powered polyp detection and analysis during colonoscopies. The funding will support commercialization in the USA and Europe and continued AI development.
2025-07
Medical Device Network
Magentiq Eye secures Series A funding to advance AI-powered colonoscopy solutions
Magentiq Eye has completed its Series A funding round, led by aMoon, to support the global expansion of its AI-based colonoscopy decision-support technology and develop new AI-powered tools for upper and lower GI indications.
2026-05
MAGENTIQ EYE
MAGENTIQ EYE Releases New MAGENTIQ-COLOu2122 Versions Expanding User Experience and AI-Based Quality Metrics in Colonoscopy
MAGENTIQ EYE released two new versions of its MAGENTIQ-COLOu2122 AI-powered colonoscopy platform, introducing an FDA-cleared AI-based endoscopic tool detection in the U.S. version and CE-marked AI-based procedural quality metrics in the European version.
2026-01
MAGENTIQ EYE
AI Can Help Address the Gap in Upper GI Quality Standards?
This article discusses how AI can help improve quality standards in upper GI endoscopy, drawing parallels with the success of AI in colonoscopy for adenoma detection. It highlights the need for better quality frameworks in upper GI procedures.
2026-06
MAGENTIQ EYE
Lancet Digital Health Study Confirms MAGENTIQ-COLOu2122 AI-aided Colonoscopy Technology Improves Adenoma Detection Rates
A comprehensive study on MAGENTIQ-COLOu2122 CADe version was published in The Lancet Digital Health, validating its high performance in AI-aided colonoscopy by increasing adenoma detection rate (ADR) by 7% and reducing adenoma miss rate (AMR) by 17%.
2024-02
Clinical Trials Arena
Magentiq's AI-aided colonoscopy tool increases adenoma detection by 7%
Data from a clinical trial assessing Magentiq-Colo CADe, published in The Lancet Digital Health journal, demonstrated the software's superiority in detecting adenomas during colonoscopy, showing a 7% absolute increase in adenomas detected.
2024-02
BioSpace
FDA Authorizes Marketing of MAGENTIQ-COLOu2122, a Cutting-Edge AI Gastrointestinal Lesion Software Detection System that Helps Detect Lesions in Real Time During Colonoscopy Procedures
MAGENTIQ-EYE LTD. announced that the U.S. FDA cleared MAGENTIQ-COLOu2122 via the 510(k) process, making the AI-powered system for real-time lesion detection during colonoscopies available in the United States.
2023-07
BioWorld
FDA clears Magentiq-Eye's AI software for colonoscopy
Magentiq-Eye Ltd. received U.S. FDA 510(k) clearance for its Magentiq-Colo, an AI gastrointestinal software system designed to detect lesions in real time during colonoscopy procedures and significantly increase the adenoma detection rate.
2023-08

Frequently Asked Questions

Magentiq Eye's primary product is MAGENTIQ-COLOu2122, an AI-powered software designed to assist gastroenterologists during colonoscopy. It uses computer-aided detection (CADe) to highlight suspicious areas, such as polyps, in real-time video output, aiming to increase adenoma detection rates and reduce miss rates.
MAGENTIQ-COLOu2122 has received FDA 510(k) clearance for its computer-aided detection (CADe) capabilities in the U.S. and is CE compliant for the European market. The CE-marked version also includes computer-aided diagnosis (CADx) features, such as polyp size estimation and characterization, and AI-based procedural quality (CAQ) metrics.
Magentiq Eye leverages deep learning and computer vision to analyze colonoscopy video frames in real-time, identifying visual characteristics consistent with mucosal abnormalities. This real-time decision support system aids endoscopists in detecting polyps, including small adenomas, which can significantly increase adenoma detection rates and decrease miss rates compared to conventional colonoscopy.
Clinical studies have demonstrated that MAGENTIQ-COLOu2122 significantly increases the adenoma detection rate (ADR) by 7% in absolute values and 26% relatively, and reduces the adenoma miss rate (AMR) by 48% relatively. These improvements are linked to a decreased occurrence of colorectal cancer and patient mortality.
Magentiq Eye offers an attractive business model with a focus on efficiency and economic value, including a monthly rental model and low upfront costs. This approach aims to provide flexible commitment and ensures access to always-updated software.
Magentiq Eye is actively forming strategic partnerships to expand its market reach, such as the distribution partnership with PENTAX Medical for the U.S. market. The company also engages in direct sales and cooperates with medical centers for data collection and algorithm improvement, indicating a commitment to ongoing support and collaboration.
Founded in 2014, Magentiq Eye recently completed a Series A funding round led by aMoon, indicating strong financial stability and investor confidence. The company has a detailed roadmap for future development, including AI tools for upper GI procedures such as detection of early dysplasia in Barrett's esophagus, upper GI landmark detection, and automated quality measurements of GI procedures.

Investors

Who's funded Magentiq Eye.

Related Companies

Intelligent Voice AI (IVAI) is an agentic AI platform that deploys AI voice agents specifically designed for healthcare, insurance, legal, and home services businesses. For physicians and medical practices, IVAI’s Evolve AI Agents act as an AI workforce, not just an answering service, handling a comprehensive range of administrative and operational tasks. These agents can […]

Dext, formerly known as Receipt Bank, is a company that specializes in bookkeeping automation, leveraging data, technology, and applied AI to enhance productivity and efficiency for businesses, accountants, and bookkeepers. [3, 16] Their platform is designed to streamline financial document management and automate bookkeeping tasks, aiming to simplify the accounting process and enable more informed […]

Cortex (https://www.cortex.app) is an AI-powered internal developer portal designed to enhance engineering excellence and streamline software development workflows. For physicians, this translates to a platform that can indirectly improve healthcare technology by enabling engineering teams to build more reliable, secure, and efficient software. The platform helps in cataloging, scoring, and assigning actions to improve service […]

Nino is an AI-powered financial planning and tax service that aims to provide comprehensive financial guidance. For physicians, Nino’s AI software can help manage income, student loans, and plan career transitions, such as moving from training to practice or considering practice ownership. The platform allows physicians to view loans, income, and savings in one place, […]

Coral AI is a healthcare artificial intelligence company that aims to streamline administrative workflows for healthcare providers, ultimately accelerating patient access to care. The company’s AI-driven platform integrates with existing healthcare systems, including EHRs, fax lines, and payer portals, to automate complex administrative tasks. This includes patient intake, prior authorizations, billing, compliance, and patient outreach. […]

SamaCare is a healthcare AI company that provides a cloud-based workflow intelligence platform designed to streamline the prior authorization process for specialty medications. The company’s platform aims to reduce the administrative burden on medical practices, improve approval rates, and add predictability to patient care. By digitizing the often manual and paper-heavy prior authorization process, SamaCare […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.